Last reviewed · How we verify

NCT04365777

EEG Characteristics of Different Sedation Depths in Neurosurgery Patients

Completed Last updated 6 February 2023
What this trial tests

trial testing OAA/S=5 in Electroencephalography in 42 participants. Completed in 5 November 2021.

Timeline
18 June 2020
Primary endpoint
5 November 2021
5 November 2021

Quick facts

Lead sponsorBeijing Tiantan Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment42
Start date18 June 2020
Primary completion5 November 2021
Estimated completion5 November 2021
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Tiantan Hospital

Who can join

Adults 18 to 60, any sex, with Electroencephalography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gliomas are the most common primary intracranial malignancy, and behavioral experiments in patients with supratentorial gliomas under sedation have shown potential neurological abnormalities; however, these behavioral experiments are susceptible to external influences. Therefore, more objective evidence is needed to support and extend the existing conclusions. The purpose of this study is to compare the EEG signatures (such as the EEG signal power) at various levels of anesthetics induced sedation in patients with supratentorial glioma in frontal lobe and in patients without intracranial-occupying lesion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Electroencephalography

Currently open trials in the same condition.

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04365777.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing